NeoGenomics
cancer genetics diagnostic testing company based in Fort Myers, Florida, USA
NEO Nasdaq
SEC CIK 1077183
Follow NeoGenomics
Weekly email: filings, results
Revenue, last quarter
$209.3M
+11.4% vs same quarter last year
Net income
−$7.5M
+72.2% vs same quarter last year
EPS, diluted
-
Operating cash flow
−$8.9M
−200% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $727.3M | −$108M |
| FY24 | $660.6M | −$79M |
| FY23 | $591.6M | −$88M |
| FY22 | $509.7M | −$144M |
| FY21 | $484.3M | −$8M |
| FY20 | $444.4M | $4.2M |
| FY19 | $408.8M | $8M |
| FY18 | $276.7M | $2.6M |
| FY17 | $240.3M | −$396K |
| FY16 | $231.8M | −$6.1M |
| FY15 | $5M | −$2.5M |
| FY14 | $5M | $1.1M |
| FY13 | $5M | $2M |
| FY12 | $5M | $65K |
| FY11 | - | −$1.2M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 43.2% | −15.9% | −14.8% |
| FY24 | 43.9% | −13.9% | −12% |
| FY23 | 41.3% | −18.2% | −14.9% |
| FY22 | 36.9% | −30.9% | −28.3% |
| FY21 | 38.6% | −24.5% | −1.7% |
| FY20 | 41.8% | −3.1% | 0.9% |
| FY19 | 48.1% | 3.2% | 2% |
| FY18 | 46% | 3.6% | 1% |
| FY17 | 42.4% | 1.2% | −0.2% |
| FY16 | 42.3% | 0.9% | −2.6% |
| FY15 | - | −112.7% | −50.7% |
| FY14 | - | 44.4% | 22.6% |
| FY13 | - | 63.5% | 40.7% |
| FY12 | - | 24.2% | 1.3% |
| FY11 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$21.8M |
| FY24 | −$34M |
| FY23 | −$30.7M |
| FY22 | −$96.9M |
| FY21 | −$90.9M |
| FY20 | −$27.6M |
| FY19 | $3.3M |
| FY18 | $30.5M |
| FY17 | $4.3M |
| FY16 | $13.9M |
| FY15 | $4.2M |
| FY14 | $5.7M |
| FY13 | $216K |
| FY12 | −$3.1M |
| FY11 | −$828K |
- NeoGenomics
- Industrials median
Show the numbers
| Year | NeoGenomics | Industrials median |
|---|---|---|
| FY25 | −14.8% | 2.5% |
| FY24 | −12% | 3.3% |
| FY23 | −14.9% | 3.7% |
| FY22 | −28.3% | 3.8% |
| FY21 | −1.7% | 3.7% |
| FY20 | 0.9% | 0.3% |
| FY19 | 2% | 3.8% |
| FY18 | 1% | 3.9% |
| FY17 | −0.2% | 4% |
| FY16 | −2.6% | 3.8% |
| FY15 | −50.7% | 4.4% |
| FY14 | 22.6% | 4.8% |
| FY13 | 40.7% | 4.9% |
| FY12 | 1.3% | 4.6% |
| FY11 | - | 4.8% |